Clinical Trial Update: Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update from Johns Hopkins evaluating glucagon-like peptide-1 receptor agonists for multiple sclerosis; the study is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Johns Hopkins University | Conditions: Multiple Sclerosis | Phase 2 | Status: RECRUITING